Changes to This $100 Billion Federal Drug Program Could Make Banks the Hidden Beneficiaries

A proposed federal drug-discount overhaul could generate billions of dollars in new borrowing demand from hospitals, potentially benefiting banks that already hold hospital credit lines. The article says the lenders best positioned to profit may be unexpected but does not identify them or quantify the potential borrowing.